SAB Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 11/14/2025 | 11.42 M | $22.95 M | 100.00% | 107.12% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 4.40 M | $8.85 M | 100.00% | 41.29% |
| COMMODORE CAPITAL LP | 11/14/2025 | 4.40 M | $8.85 M | 100.00% | 41.29% |
| WOODLINE PARTNERS LP | 11/14/2025 | 2.85 M | $5.73 M | 100.00% | 26.74% |
| SESSA CAPITAL IM, L.P. | 11/14/2025 | 2.20 M | $4.42 M | 379.53% | 20.62% |
| BVF INC/IL | 11/14/2025 | 932.70 K | $1.87 M | 1.62% | 8.75% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 566.40 K | $1.14 M | 100.00% | 5.31% |
| VANGUARD GROUP INC | 11/07/2025 | 365.75 K | $735.16 K | 29.53% | 3.43% |
| HB WEALTH MANAGEMENT, LLC | 10/23/2025 | 307.50 K | $618.08 K | 100.00% | 2.88% |
| AWM INVESTMENT COMPANY, INC. | 11/13/2025 | 200.00 K | $402.00 K | 100.00% | 1.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 85.72 K | $172.32 K | 1.12% | 0.80% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 80.84 K | $162.49 K | 632.91% | 0.76% |
| PATHSTONE HOLDINGS, LLC | 11/13/2025 | 50.65 K | $101.81 K | 0.00% | 0.48% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 19.98 K | $40.00 K | 100.00% | 0.19% |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | 11/10/2025 | 19.20 K | $38.59 K | 0.00% | 0.18% |
| FIRST PREMIER BANK | 10/15/2025 | 18.99 K | $38.00 K | 0.00% | 0.18% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 15.78 K | $31.72 K | 100.00% | 0.15% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 15.00 K | $30.15 K | 100.00% | 0.14% |
| UBS GROUP AG | 11/13/2025 | 13.22 K | $26.57 K | 24.05% | 0.12% |
| KESTRA ADVISORY SERVICES, LLC | 11/14/2025 | 11.93 K | $23.98 K | 0.00% | 0.11% |
| NORTHERN TRUST CORP | 11/14/2025 | 11.39 K | $22.89 K | 0.00% | 0.11% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 11.22 K | $22.55 K | 100.00% | 0.11% |
| CAXTON CORP | 11/14/2025 | 10.94 K | $21.98 K | 100.00% | 0.10% |
| BLACKROCK, INC. | 11/12/2025 | 6.34 K | $12.74 K | -9.52% | 0.06% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 4.82 K | $9.99 K | -2.29% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.56 K | $3.14 K | 114.88% | 0.01% |
| CITIGROUP INC | 11/10/2025 | 832 | $1.67 K | 100.00% | 0.01% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 217 | $437 | 0.00% | 0.00% |
| GS INVESTMENTS, INC. | 11/06/2025 | 200 | $402 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 168 | $338 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 87 | $175 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 74 | $149 | 1.37% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 52 | $105 | 4.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/12/2025 | 50 | $101 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CREATIVE PLANNING | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SACHETTA, LLC | 10/24/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
SAB Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 11.42 M
RA CAPITAL MANAGEMENT, L.P.: 4.4 M
COMMODORE CAPITAL LP: 4.4 M
Woodline Partners LP: 2.85 M
Sessa Capital IM, L.P.: 2.2 M
BVF INC/IL: 932,697
262.88% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.09 M shares in the last 24 months. This purchase volume represents approximately $59.93 M in transactions.